A two-day conference on “Current usage of nanotheraputics and Biodrugs” on Wednesday commenced here at Faisal Masjid campus of the International Islamic University Islamabad (IIUI).
The conference is organized by the Department of Bioinformatics and Biotechnology of the Faculty of Basic and Applied Sciences of IIUI in collaboration with Higher Education Commission.
Inaugural ceremony was joined by the Vice Chancellor Quaid e Azam University (QAU) Dr. Muhammad Ali who stressed upon detailed research on the impact of medicines on human body. He added that every human has different medical attitude of his body and medicines may very case to case and human body situation.
“Nano technology is a bliss which is narrowed down and focused approach to deal with the disease as rest of the cells in the body remain safe” he said while talking about advancement in technology and use of new science.
Dr. Aqdas N
aveed Malik, Acting IIUI President called for providing an environment of exchange of experiences to the experts of biodrugs and nanotheraputics . He hoped that the conference will be proved as a platform to come up with best practical recommendations in the field of nano-technology and bio drugs.
The organizer of the conference Dr. Sobia Tabassum cordially welcomed the renowned scientists and conference participants from all over Pakistan. She addressed the unique aspect of this con
ference to focus on advanced research-based incorporation of cost effective therapeutics in clinical practice which will help to provide quality healthcare to society. She further concluded that the commencement of this conference is an immense footstep to contribute in university success and ranking.
The organizing faculty Dr. Sobia Tabassum (Associate Professor), Dr. Muhammad Imran Shabbir, (Assistant Professor, conference secretary) and Ayesha Aftab (Research Associate, conference organizer) expressed their views on the occasion that conference is aimed at gathering the best researchers and biodrugs specialist for exchange of experiences. They told that it will also discuss new avenues of entrepreneurship in nanotherapeutics.